SCHEMBL8285348

SCHEMBL8285348

O=C(CCCCCC(=O)N(CC(=O)NCCc1c[nH]c2ccccc12)CC(=O)NCCc1c[nH]c2ccccc12)NO

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
HDAC1 Q13547 3/20 0.57
HDAC2 Q92769 2/20 0.57
HDAC6 Q9UBN7 2/20 0.57
HDAC3 O15379 1/20 0.57
HDAC4 P56524 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC11 Q96DB2 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC9 Q9UKV0 1/20 0.57
HDAC5 Q9UQL6 1/20 0.57
MMP9 P14780 1/20 0.57
AANAT Q16613 1/20 0.57
MAPT P10636 2/20 0.55
UBE2N P61088 1/20 0.55
ALDH1A1 P00352 2/20 0.55
NPC1 O15118 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12672064 0.89 MEN1 (0.81) MTNR1AMEN1KMT2AHDAC1HDAC2
SCHEMBL2808670 0.89 MEN1 (0.81) MTNR1AMEN1KMT2AHDAC1HDAC2
SCHEMBL1233057 0.88 MEN1 (0.83) MTNR1AMEN1KMT2AHDAC1HDAC2
SCHEMBL1305483 0.82 MEN1 (0.67) MTNR1AMEN1KMT2AHDAC1HDAC2
SCHEMBL1726877 0.80 MEN1 (0.81) MTNR1AMEN1KMT2AMMP9AANAT
SCHEMBL1233177 0.80 MEN1 (0.81) MTNR1AMEN1KMT2AMMP9AANAT
SCHEMBL1234076 0.79 HDAC1 (0.69) MTNR1AMEN1KMT2AHDAC1HDAC2
SCHEMBL1066221 0.79 MTNR1A (1.00) MTNR1AMEN1KMT2AAANATMAPT
SCHEMBL3806536 0.79 MTNR1A (1.00) MTNR1AMEN1KMT2AAANATMAPT
SCHEMBL22411433 0.79 MTNR1A (1.00) MTNR1AMEN1KMT2AAANATMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023718-A1 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives ATON PHARMA, INC. (US) 2009-01-22 US disclosed
US-20090023718-A1 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives ATON PHARMA, INC. (US) 2009-01-22 US disclosed
WO-2005053610-A2 DIAMINE AND IMINODIACETIC ACID HYDROXAMIC ACID DERIVATIVES ATON PHARMA, INC. (US) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023718-A1 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives AADAC, BRDT, HDAC5 MTNR1A 561/4885MEN1 3081/4885KMT2A 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.